Table 4.
Variable | N | X̄±s.e.m. | 95% CI | Q | P | I2 |
---|---|---|---|---|---|---|
Primary outcomes (mg/dl) | ||||||
TC | 17 | −3.4±1.7 | −6.7 to −0.2* | 22.8 | 0.12 | 29.7 |
HDL | 15 | 1.6±0.8 | −0.02 to 3.2 | 46.4 | <0.001** | 69.8 |
LDL | 14 | −0.5±1.3 | −3.0 to 2.0 | 12.9 | 0.46 | 0.0 |
TG | 14 | −16.1±7.3 | −30.2 to −2.1* | 58.7 | <0.001** | 77.9 |
Secondary outcomes | ||||||
Body weight (kg) | 14 | −1.6±0.4 | −2.3 to −0.9* | 25.0 | 0.02** | 48.1 |
BMI (kg/m2) | 5 | −1.1±0.3 | −1.8 to −0.5* | 6.1 | 0.19 | 34.2 |
Body fat (%) | 5 | −0.1±0.3 | −0.8 to 0.6 | 4.2 | 0.38 | 4.2 |
VO2max (ml/kg−1/min−1) | 10 | 3.5±0.6 | 2.3 to 4.7* | 55.2 | <0.001** | 83.7 |
N, number of groups reporting data in which a treatment effect could be calculated; X̄±s.e.m., mean±standard error of the mean; CI, confidence interval; Q, heterogeneity value; P, significance value for Q; I2, percentage (%) of inconsistency for study results, calculated from Q statistic; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglycerides; BMI, body mass index; VO2max, maximum oxygen consumption.
Significantly different from zero (0);
statistically significant at P<0.05.